Graphite Capital Sells Beacon to Corten Capital with 4x Return
Graphite Capital is set to sell Beacon, a life sciences data platform, to Corten Capital, achieving a projected 4x return on investment. The transaction is expected to finalize by June 2026, with Graphite retaining control of Hanson Wade for future growth.
Theia Market Signal Identification - AI Assisted
Graphite Capital has finalized an agreement to sell Beacon, a life sciences data and workflow platform, to Corten Capital, anticipated to yield a 4x cash return on its 2019 investment. The sale is expected to conclude by the end of June 2026.
Under Graphite's stewardship, Beacon's annual recurring revenues have increased thirteenfold, driven by enhancements in datasets and integration of AI workflows. The platform expanded from three to sixteen datasets, focusing on areas such as oncology and neuroscience.
Graphite will maintain control over the Hanson Wade business, which it plans to develop further, while Beacon aims to strengthen its global presence and product offerings. This deal underscores the increasing reliance on data in R&D decision-making, potentially reshaping competitive dynamics in the life sciences sector.
Comments